Physician profile
Robert Jay Still
NPI 1659373801
$16,937.03
in general payments reported to CMS, 2019-2025
31 companies · $82.18 in 2025
The $82.18 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,326 · 2020: $4,475 · 2021: $4,776 · 2022: $804 · 2023: $596 · 2024: $878 · 2025: $82.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,147.50 | 2019-2021 | |
| Abiomed | $1,561.66 | 2019-2025 | Impella |
| Medtronic, INC. | $1,176.70 | 2021-2025 | Onyx Frontier, Endurant Iis |
| Artivion, INC. | $878.06 | 2019-2023 | Photofix Decellularized Bovine Pericardium, Bioglue Surgical Adhesive, Cardiac Non-Synergraft |
| Endologix LLC | $812.32 | 2019 | |
| Medtronic Vascular, INC. | $503.94 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $489.89 | 2019-2022 | |
| Silk Road Medical, INC. | $475.44 | 2021 | |
| Atricure, INC. | $423.71 | 2019-2023 | |
| Edwards Lifesciences Corporation | $343.60 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $150.50 | 2019-2021 | |
| Clearflow INC. | $129.19 | 2019-2022 | |
| Baxter Healthcare | $123.30 | 2021-2024 | Preveleak |
| Kerecis Limited | $89.94 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Davol INC. | $88.46 | 2020-2024 | Progel Applicator Spray Tips |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $67.29 | 2021 | |
| Lemaitre Vascular, INC. | $62.70 | 2019-2023 | Restoreflow |
| Ethicon US, LLC | $62.03 | 2019-2025 | Echelon Endopath, Echelon Flex, Harmonic |
| Lsi Solutions INC | $55.53 | 2021-2022 | |
| Kls-Martin L.P. | $47.13 | 2019-2022 | |
| Hemosonics LLC | $42.11 | 2024 | Quantra Qplus System, Qunatra Qplus System |
| Covidien Lp | $38.60 | 2019 | |
| Kci USA, INC. | $33.17 | 2021-2022 | |
| Integra Lifesciences Corporation | $26.80 | 2020 | |
| Misonix INC | $22.64 | 2020 | |
| Bard Peripheral Vascular, INC. | $21.63 | 2021 | |
| Acera Surgical, INC. | $17.58 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $17.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.58 | 2019 | |
| Ethicon INC. | $13.60 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Still listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.